Xu Zhang

Dr. Xu Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
XZXu Zhang
Xu Zhang
CYChunhong Yu
Chunhong Yu
PWPeng Wang
Peng Wang
CYChunping Yang
Chunping Yang
The increasing prevalence of microplastics (MPs) in the environment has raised urgent concerns regarding their implications for human health. This comprehensive review integrates recent findings on the sources, classification, and pathways of MPs into the human body, highlighting their potential cellular toxicity and systemic health risks. We discuss the mechanisms by which MPs may induce inflammatory responses, oxidative stress, and cellular damage, thereby contributing to various diseases. Notably, we examine the synergistic effects of MPs in conjunction with other environmental pollutants, which may amplify their adverse health outcomes. This synthesis of current research underscores the critical need for multidisciplinary approaches to investigate the multifaceted interactions between MPs and human health, ultimately guiding future studies and informing public health strategies to mitigate exposure and associated risks.

1 January 2026 in International Journal of Biological Sciences
Verified
Journal Article
Open access
PDF file
XZXu Zhang
Xu Zhang
ZZZhiqiang Zhang
Zhiqiang Zhang
QPQian Peng
Qian Peng
XHXinyu Huang
Xinyu Huang
MLMengyuan Liu
Mengyuan Liu
CYChunping Yang
Chunping Yang
Allergic Rhinitis (AR) is a highly prevalent type 2 inflammatory disease driven by a complex immunogenetic background. This review aims to systematically delineate the immunogenetic landscape of AR, elucidating the complete knowledge chain from macroscopic cellular interactions and microscopic molecular regulation to precision targeted therapies. The article first dissects the two core immune axes driving the pathological process of AR: one is the classic adaptive immune pathway, centered on Th2 cells, which mediates IgE production, eosinophil infiltration, and mucus hypersecretion through the secretion of cytokines such as IL-4, IL-5, and IL-13; the other is the innate immune initiation pathway, in which nasal epithelial cells act as "sentinels" by releasing "alarmins" like TSLP and IL-33, leading to the rapid activation of type 2 innate lymphoid cells (ILC2s). The review then delves into the sophisticated signaling networks that regulate these immune responses, with a particular focus on the classic IL-4/STAT6/GATA3 signaling axis and its negative regulatory mechanisms. Building on this, the article further elaborates on the genetic susceptibility architecture of AR, highlighting key risk loci identified by genome-wide association studies (GWAS), such as variants in antigen presentation genes (HLA), epithelial barrier genes (FLG), and genes related to cytokine signaling pathways. To connect genetics with the environment, this review systematically summarizes epigenetic regulatory mechanisms, including DNA methylation, histone modifications, and microRNAs (miRNAs), and discusses the long-range immunomodulatory effects of nasal and gut microbiota dysbiosis on AR via the "gut-nasal axis". Finally, from a translational medicine perspective, the article demonstrates how a profound understanding of these pathophysiological mechanisms has successfully spurred the development of highly effective targeted biologics, such as omalizumab (targeting IgE), dupilumab (targeting the IL-4Rα receptor, thus blocking IL-4/IL-13 signaling), and tezepelumab (targeting TSLP). This review integrates the latest multidimensional research advances in immunology, genetics, epigenetics, and microbiome studies of AR, providing a comprehensive theoretical framework for understanding its complex pathogenesis and for the development of future personalized treatment strategies.

18 October 2023 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
XZXu Zhang
Xu Zhang
BGBing Guan
Bing Guan
BGBing Guan
Bing Guan
Background: The etiology and pathophysiological mechanisms of sudden sensorineural hearing loss (SSNHL) remain unclear, but it is generally believed to be associated with viral infections, vascular diseases, and autoimmune disorders. Considering that coronavirus disease 2019 (COVID‐19) is promising candidates for SSNHL, we studied the immune cells changes by COVID‐19 in patients with SSNHL.Methods: We collected data from 47 patients with SSNHL and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) positive. Patients were divided into ineffective or effective groups based on the degree of hearing recovery at discharge. Clinical information was collected and processed for both groups. Logistic regression models were used to determine the risk factors for an unfavorable prognosis in COVID‐19‐related SSNHL. Receiver operating characteristic (ROC) curves were used to estimate the predictive value.Results: There was statistically significant difference in C‐reactive protein (CRP), auditory curve, degree decline, pretreatment hearing, posttreatment hearing, systolic blood pressure, diastolic blood pressure, total bilirubin, neutrophil‐to‐lymphocyte ratio (NLR), systemic immune‐inflammation index (SII), indirect‐bilirubin and platelet count between groups (p < 0.05). In the logistic regression model, high levels of SII and NLR were associated with treatment ineffectiveness, pre‐ and postcorrectively (both, p < 0.05). And ROC curve analysis showed higher AUC of 0.765 for SII, 0.697 for NLR,0.681 for CRP, and 0.553 for platelet‐to‐lymphocyte ratio (PLR) in predicting treatment outcomes.Conclusion: The prognosis of COVID‐19‐related SSNHL was associated with inflammation. SII, NLR and CRP could serve as predictive markers of unfavorable outcomes in COVID‐19‐related SSNHL. SII may be considered an independent risk factor for poor prognosis in COVID‐19‐related SSNHL.

1 October 2025 in Environmental Research
Verified
Journal Article
Closed access
XZXu Zhang
Xu Zhang
MLMengyuan Liu
Mengyuan Liu
ZZZhiqiang Zhang
Zhiqiang Zhang
XHXinyu Huang
Xinyu Huang
DBDaoming Bai
Daoming Bai
CYChunping Yang
Chunping Yang

17 June 2025 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
XZXu Zhang
Xu Zhang
JWJunyi Wu
Junyi Wu
WZWentao Zhang
Wentao Zhang
MWMaohua Wang
Maohua Wang
BGBing Guan
Bing Guan
CYChunpin Yang
Chunpin Yang
Background: This study mainly explores the correlation between prognostic nutritional index (PNI) and systemic immune inflammatory index (SII) and sudden sensorineural hearing loss (SSNHL).Methods: In this study, 150 SSNHL patients (average age 48.98 ± 16.45 years; 48.92% male, 50.93% female) were categorized into effective and ineffective treatment groups. Additionally, 150 healthy volunteers (average age 49.49 ± 9.75 years; 51.08% male, 49.07% female) served as the control group. Baseline characteristics, clinical data, and laboratory results were collected, and SII and PNI were calculated for analysis. Linear correlation, logistic regression, and receiver characteristic curve analyses were conducted to explore the link between immune nutrition levels and SSNHL.Results: In the SSNHL group, PNI was significantly lower, while SII, platelet, and neutrophil counts were notably higher compared to controls (p < 0.001). Logistic regression identified low PNI (OR = 0.878), high SII (OR = 1.005), and elevated neutrophils (OR = 1.758) as predictors of SSNHL. Data comparison showed higher nutritional levels in the effective treatment group than in the ineffective group. Logistic regression indicated that low PNI (OR = 1.075) and high SII (OR = 1.004) were strongly linked to treatment outcomes.Conclusion: There is a relationship between the body's immune nutrition level and the occurrence and development of SSNHL. Lower PNI and higher SII are associated with the occurrence of SSNHL and poor outcomes. However, further research into the underlying mechanisms is needed.

3 May 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
XZXu Zhang
Xu Zhang
ACAijuan Cao
Aijuan Cao
QDQiuling Dang
Qiuling Dang
WZWentao Zhang
Wentao Zhang
YZYao Zhang
Yao Zhang
YHYunlong Hu
Yunlong Hu